Various Clinical Types of Q-fever Disease
-
- ARASHIMA Yasutomo
- Department of Laboratory Medicine, Nihon University School of Medicine
-
- KATO Kimitoshi
- Third Department of Internal Medicine, Nihon University School of Medicine
-
- KOMIYA Tomoyoshi
- Department of Research and Development, Research Center for Biologicals, The Kitasato Institute
-
- KUMASAKA Kazunari
- Department of Laboratory Medicine, Nihon University School of Medicine
-
- MATSUKAWA Yoshihiro
- First Department of Internal Medicine, Nihon University School of Medicine
-
- MURAKAMI Masato
- First Department of Internal Medicine, Nihon University School of Medicine
-
- TAKAHASHI Katsuyuki
- Clinical Laboratory Department, Nihon University School of Medicine
-
- IKEDA Tadao
- Department of Biology, Nihon University School of Medicine
-
- ARAKAWA Yasuyuki
- Third Department of Internal Medicine, Nihon University School of Medicine
書誌事項
- タイトル別名
-
- Improvement of Chronic Nonspecific Symptoms by Long-term Minocycline Treatment in Japanese Patients with Coxiella burnetii Infection Considered to Have Post-Q Fever Fatigue Syndrome
この論文をさがす
説明
Objective To address the presence of post-Q fever fatigue syndrome (post-QFS) in Japan, and to evaluate the efficacy of minocycline for this condition.<BR> Patients and Methods In 20 Coxiella burnetii (C. burnetii) seropositive patients with persistent nonspecific symptoms including general fatigue, low-grade fever, myalgia and arthralgia, changes in subjective symptoms, C. burnetii antibody titers and C. burnetii DNA were evaluated after antibiotic treatment.<BR> Results After treatment mainly with minocycline (100 mg/day for 3 months), the clinical picture improved in all 20 patients as evidenced by decreases in body temperature (13/17), general fatigue (20/20) and headache (9/12). The mean performance status (PS) score improved from 5.0 to 1.8 (p<0.01). All 7 who had been positive for C. burnetii DNA, became negative together with an improvement in subjective symptoms. Indirect immunofluorescence tests demonstrated 6 of the 20 patients to be positive for C. burnetii IgM antibody to phase II antigen (1:32), and 18 to be positive for IgG antibody (1:128, 1:256). Antibody titers of both IgM (6/6, 1:16) and IgG (18/18, 1:16) decreased markedly after treatment.<BR> Conclusion These results of an open label study in Japan suggest that minocycline administration is useful for improving chronic nonspecific symptoms considered to be post-Q fever fatigue syndrome caused by C. burnetii infection.
収録刊行物
-
- Internal Medicine
-
Internal Medicine 43 (1), 49-54, 2004
一般社団法人 日本内科学会
- Tweet
詳細情報 詳細情報について
-
- CRID
- 1390001204867093888
-
- NII論文ID
- 10011958857
- 10011959141
-
- NII書誌ID
- AA10827774
-
- COI
- 1:CAS:528:DC%2BD2cXjtlGjtrs%3D
-
- ISSN
- 13497235
- 09182918
-
- NDL書誌ID
- 6828776
-
- 本文言語コード
- en
-
- 資料種別
- journal article
-
- データソース種別
-
- JaLC
- NDLサーチ
- Crossref
- PubMed
- CiNii Articles
- OpenAIRE
-
- 抄録ライセンスフラグ
- 使用不可